SKIP CONTENT ACCESS NAVIGATION SEARCH SITE ADVANCED HEALTH TOPICS DATA MEDIA CENTRE PUBLICATIONS GOVERNANCE LANGUAGE ENGLISH FRANAIS NEWS RELEASES PREVIOUS STATEMENTS NOTES MEDIA EVENTS DAYS MEETINGS FACT SHEETS FACT FILES QUESTIONS ANSWERS FEATURES MULTIMEDIA CONTACTS EBOLA VIRUS DISEASE FACTS FORMERLY KNOWN EBOLA HAEMORRHAGIC FEVER ILLNESS THE VIRUS PEOPLE WILD ANIMALS HUMAN POPULATION AVERAGE CASE FATALITY RATE CASE FATALITY RATES PAST OUTBREAKS REMOTE CENTRAL TROPICAL RAINFORESTS RECENT WEST AFRICA INVOLVED MAJOR URBAN RURAL AREAS COMMUNITY ENGAGEMENT GOOD CONTROL CASE MANAGEMENT SURVEILLANCE CONTACT TRACING LABORATORY SAFE SOCIAL MOBILISATION SUPPORTIVE CARE REHYDRATION SYMPTOMATIC TREATMENT IMPROVES LICENSED PROVEN RANGE IMMUNOLOGICAL DRUG THERAPIES UNDER DEVELOPMENT EBOLA POTENTIAL CANDIDATES BACKGROUND CAUSES FIRST APPEARED IN 2 NZARA SOUTH THE OTHER YAMBUKU DEMOCRATIC REPUBLIC OF CONGO VILLAGE EBOLA RIVER THE DISEASE TAKES THE CURRENT WEST CASES LARGEST COMPLEX DISCOVERED DEATHS SPREAD GUINEA BORDERS SIERRA LEONE NIGERIA SENEGAL MALI LIBERIA SIERRA WEAK LACK HUMAN RECENTLY PERIODS CONFLICT INSTABILITY THE WHO THE WEST AFRICA PUBLIC HEALTH EMERGENCY OF INTERNATIONAL CONCERN THE INTERNATIONAL REGULATIONS FAMILY FILOVIRIDAE CUEVAVIRUS MARBURGVIRUS EBOLAVIRUS SPECIES BUNDIBUGYO BUNDIBUGYO EBOLAVIRUS ZAIRE EBOLAVIRUS SUDAN EBOLAVIRUS IN AFRICA CAUSING WEST AFRICAN BELONGS TO ZAIRE TRANSMISSION THOUGHT FRUIT BATS PTEROPODIDAE NATURAL CLOSE CONTACT SECRETIONS BODILY FLUIDS INFECTED FOREST ANTELOPE PORCUPINES ILL DEAD THE RAINFOREST DIRECT CONTACT BROKEN SKIN MUCOUS MEMBRANES MATERIALS CONTAMINATED WORKERS TREATING PATIENTS CONFIRMED INFECTION CONTROL BURIAL CEREMONIES THE BODY DECEASED PERSON PLAY ROLE INFECTIOUS BLOOD SEXUAL TRANSMISSION RESEARCH RISKS PARTICULARLY PREVALENCE VIRUS SEMEN OVER TIME PRESENT SURVIVORS SEXUAL PARTNERS SHOULD ENSURE SEXUAL PRACTICES TWICE TESTED MALE TESTING AT 3 MONTHS ONSET MONTH NEGATIVE INTERVAL WEEK ABSTAIN OBSERVE SAFE SEX CONSISTENT CONDOM RESUME NORMAL WITHOUT FEAR ANALYSIS ONGOING CONSIDERATION GROUP PRACTICE HYGIENE SYMPTOMS HAND PERSONAL HYGIENE IMMEDIATELY WASHING SOAP AND WATER PHYSICAL CONTACT PERIOD CONDOMS HANDLED PREVENT PARTNERS FAMILIES DIGNITY READ GUIDANCE CARE INCUBATION PERIOD TIME INTERVAL INFECTION 21 DAYS HUMANS DEVELOP SUDDEN FEVER MUSCLE PAIN HEADACHE SORE THROAT VOMITING DIARRHOEA KIDNEY LIVER FUNCTION INTERNAL EXTERNAL FINDINGS WHITE BLOOD CELL PLATELET COUNTS ELEVATED LIVER ENZYMES DIAGNOSIS DISTINGUISH INFECTIOUS DISEASES TYPHOID FEVER CONFIRMATION CAUSED IMMUNOSORBENT ASSAY DETECTION SERUM NEUTRALIZATION REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION ASSAY ELECTRON MICROSCOPY VIRUS ISOLATION CELL CULTURE EXTREME CONDUCTED MAXIMUM BIOLOGICAL CONTAINMENT INTRAVENOUS FLUIDS AVAILABLE IMMUNE SAFETY PREVENTION RAISING AWARENESS RISK FACTORS EBOLA INFECTION INDIVIDUALS EFFECTIVE REDUCE RISK REDUCTION MESSAGING FOCUS THE CONSUMPTION RAW MEAT GLOVES PROTECTIVE CLOTHING ANIMAL COOKED DIRECT PERSONAL PROTECTIVE EQUIPMENT WORN TAKING REGULAR HAND WASHING POSSIBLE BODY FLUIDS ISOLATION FEMALE WHOSE CONTAINMENT PROMPT BURIAL OF THE DEAD SOMEONE MONITORING IMPORTANCE HEALTHY THE SICK MAINTAINING CLEAN ALWAYS STANDARD PRECAUTIONS PRESUMED HAND HYGIENE RESPIRATORY BLOCK INJECTION APPLY EXTRA CLOTHING FACE PROTECTION FACE SHIELD MEDICAL MASK FOR SOME AT RISK TAKEN INVESTIGATION TRAINED STAFF LABORATORIES RESPONSE DEVELOPED PREPAREDNESS DOCUMENT OVERALL MARBURG VIRUS MARBURG VIRUS DISEASE EVALUATION DETECTED LOGISTICAL SUPPORT TRAINING ASSISTANCE ADVICE INFECTION PREVENTION FILOVIRUS HAEMORRHAGIC FEVER CHRONOLOGY WEST AFRICAN EBOLA OUTBREAK STORIES RELATED LINKS FAQS STRATEGIC PLAN WEST AFRICA EBOLA OUTBREAK TECHNICAL THE FIELD BEYOND HEALTH WORKERS BEGIN HOPEFULLY FUTURE ITALY 13 MAY UNITED KINGDOM 30 DECEMBER 2014 EBOLA VIRUS DISEASE SPAIN YOU ARE HERE QUICK SITEMAP PROJECTS HELP EMPLOYMENT FEEDBACK PRIVACY SCAMS REGIONAL OFFICES AFRICAN REGION WHO REGION THE AMERICAS ASIA REGION EUROPEAN REGION EASTERN MEDITERRANEAN WESTERN PACIFIC REGION EMAIL ADDRESS SIGN UPDATES